Registry for evaluating lipid-lowering therapy in high-risk heart patients
Hyperlipidemia Therapy in tERtiary Cardiological cEnTer Zabrze Registry
This study is testing how well cholesterol-lowering treatments work for people with severe heart disease to see if they can help them reach healthier cholesterol levels and improve their overall health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Silesian Centre for Heart Diseases Academic / other |
| Locations | 1 site (Zabrze, Upper Silesia) |
| Trial ID | NCT03065543 on ClinicalTrials.gov |
What this trial studies
The Hyperlipidemia Therapy TERCET Zabrze Registry is an observational study aimed at assessing the effectiveness of lipid-lowering treatments in patients with coronary artery disease who are at high and very high risk. It collects comprehensive data on patient demographics, medical history, and treatment outcomes, focusing on achieving target LDL cholesterol levels at one-year follow-up. The study also evaluates trends in lipid-lowering therapy over time and the relationship between lipid profiles and the severity of coronary artery disease. Patients are monitored for all-cause mortality and major adverse events during follow-up.
Who should consider this trial
Good fit: Ideal candidates include patients hospitalized with coronary artery disease who also have hyperlipidemia.
Not a fit: Patients without a diagnosis of coronary artery disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with hyperlipidemia and coronary artery disease.
How similar studies have performed: Other studies have shown success in evaluating lipid-lowering therapies in similar high-risk populations, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with coronary artery disease with hyperlipidemia Exclusion Criteria: * No coronary artery disease
Where this trial is running
Zabrze, Upper Silesia
- Silesian Center for Heart Diseases — Zabrze, Upper Silesia, Poland (Recruiting)
Study contacts
- Principal investigator: Mariusz Gasior, prof.MD,PhD — 3rd Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia, Katowice, Poland
- Study coordinator: Krzysztof Dyrbus, MD, PhD
- Email: dyrbusk@gmail.com
- Phone: +48600213030
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.